Pro Medicus (ASX:PME) Secures AU$98M, 8-Year Contract Renewal with Mercy Health

Key Points:

1. Pro Medicus' U.S. subsidiary signs an eight-year contract renewal with Mercy Health, valued at A$98 million.
2. The deal includes Visage 7 Viewer and Visage 7 Open Archive, with a higher per-transaction fee compared to the original contract.
3. The renewal reflects confidence in Pro Medicus' offerings and the Visage platform's financial and clinical value.

Pro Medicus Limited (ASX:PME), a leading health imaging company, has announced that its U.S. subsidiary, Visage Imaging, Inc., has secured an eight-year contract renewal with St. Louis-based Mercy Health. This contract, valued at a minimum of A$98 million, covers the use of Visage 7 Viewer and Visage 7 Open Archive, two of Pro Medicus' flagship health imaging solutions.

Contract Renewal Details

The renewal builds on a strong existing partnership between Pro Medicus and Mercy Health, one of the largest health systems in the United States. Notably, this agreement comes with several advantageous terms for Pro Medicus. The contract is transaction-based, meaning revenue will be generated based on the volume of transactions processed through the company's software solutions. Additionally, the new agreement has been negotiated at a higher per-transaction fee compared to the original contract. This change not only reflects the value Mercy Health sees in the Visage solution but also ensures Pro Medicus stands to benefit from any potential increases in transaction volume over the contract's lifespan.

Another significant aspect of the deal is its duration. While the original contract had a term of seven years, this renewal extends the partnership to eight years, reflecting Mercy Health’s confidence in the Visage platform. In an industry where renewals typically come with shorter extensions and often at lower prices, this long-term renewal at an increased fee highlights the strong performance and value delivered by Pro Medicus' offerings.

Visage 7 Viewer and Open Archive: Key Solutions

The renewed contract covers two critical products in Pro Medicus' suite: Visage 7 Viewer and Visage 7 Open Archive. These tools are central to modern medical imaging, providing health institutions with advanced capabilities for viewing, storing, and managing clinical imaging data.

Visage 7 Viewer is an innovative platform that allows clinicians to view and interpret medical images in real-time, significantly improving workflow efficiency and diagnostic accuracy. The solution's speed and scalability are crucial for large health systems like Mercy Health, which handles vast amounts of patient data daily.

Visage 7 Open Archive complements the viewer by offering a robust, scalable platform for the long-term storage and retrieval of imaging data. It enables healthcare providers to manage and archive medical images in a way that ensures data integrity, security, and accessibility across the health system. Together, these solutions provide a comprehensive imaging system that enhances both clinical and operational outcomes.

Strategic Importance and Market Confidence

This contract renewal with Mercy Health is a major milestone for Pro Medicus, reaffirming its position as a leader in the medical imaging sector. Dr. Sam Hupert, CEO of Pro Medicus, emphasized the significance of this renewal, particularly in the context of industry trends. "The industry norm for renewals is for short extensions to the original contract at the same or lower price," Hupert explained. "The fact that Mercy has renewed for a longer contract term and at an increased price shows confidence in our offering and reinforces our belief that the Visage solution delivers unparalleled value in terms of both financial and clinical ROI."

The increased per-transaction fee also signals growing market confidence in the Visage solution's ability to deliver both financial returns and clinical efficiencies. By securing a higher rate for its services, Pro Medicus demonstrates its commitment to providing cutting-edge technology that meets the evolving needs of large health systems like Mercy Health.

Looking Forward

As the healthcare industry continues to evolve, with an increasing emphasis on digital transformation and efficiency, Pro Medicus is well-positioned to capitalize on growing demand for its advanced imaging solutions. The transaction-based nature of the contract offers Pro Medicus potential upside as Mercy Health expands its use of Visage technology, particularly if the volume of transactions increases over time.

This renewal not only strengthens Pro Medicus' relationship with Mercy Health but also underscores the broader market's recognition of the value the company brings to healthcare institutions. With a robust portfolio of innovative imaging solutions and a proven ability to deliver strong financial and clinical outcomes, Pro Medicus is poised for continued growth and success.